SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

91.32

273565.37

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.29

Back

Aditya Birla Real Estate reports consolidated net profit of Rs 858.50 crore in the September 2026 quarter

Oct 26,2026

Net profit of Aditya Birla Real Estate reported to Rs 858.50 crore in the quarter ended September 2026 as against net loss of Rs 15.74 crore during the previous quarter ended September 2025. Sales rose 751.78% to Rs 824.27 crore in the quarter ended September 2026 as against Rs 96.77 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	824.27	96.77	752
OPM %	19.16	-76.22	-
PBDT	193.77	-76.10	LP
PBT	173.79	-91.83	LP
NP	858.50	-15.74	LP

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)